Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 29Gynecologic 2Gastrointestinal 1Dermatologic 1

Conditions

Melanoma 147Carcinoma, Non-Small-Cell Lung 34Skin Neoplasms 28Colorectal Neoplasms 28Breast Neoplasms 25Lung Neoplasms 24Carcinoma, Renal Cell 21Ovarian Neoplasms 20Neoplasms 20Squamous Cell Carcinoma of Head and Neck 19Carcinoma, Basal Cell 19Carcinoma, Merkel Cell 18Sarcoma 17Prostatic Neoplasms 17Pancreatic Neoplasms 16Neoplasm Metastasis 15Head and Neck Neoplasms 14Stomach Neoplasms 13Thyroid Neoplasms 12Uterine Cervical Neoplasms 11Urinary Bladder Neoplasms 11Carcinoma, Hepatocellular 11Lymphoma, T-Cell, Cutaneous 10Esophageal Neoplasms 10Carcinoma, Transitional Cell 9Uveal Melanoma 8Triple Negative Breast Neoplasms 8Mycosis Fungoides 8Colonic Neoplasms 8Small Cell Lung Carcinoma 7

Interventions

cabozantinib 1Specimen Handling 1Nivolumab 1Magnetic Resonance Spectroscopy 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Oropharyngeal Neoplasms × Dermatologic × 30 days × Clear all
NCT05136196 2026-06-03

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

National Cancer Institute (NCI)

Phase 2 Recruiting
150 enrolled
DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Melanoma, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡